Childhood cancer and the Jehovah's Witness faith. (avaa uuden ikkunan)

Frankel LS, Damme CJ, Eys JV.

Lähde‎: Pediatrics 1977;60(6):916-21.

Arkistoitu‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (avaa uuden ikkunan)

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531. (avaa uuden ikkunan)

Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L, Glick K, Davies SM, Byron P, Smith FO, Aplenc R

Lähde‎: J Clin Oncol 2014;32(27):3021-32.

Arkistoitu‎: PubMed 25092781

DOI‎: 10.1200/JCO.2014.55.3628

https://www.ncbi.nlm.nih.gov/pubmed/25092781 (avaa uuden ikkunan)

Red blood cell transfusion and outcome in cancer. (avaa uuden ikkunan)

Iqbal N, Haider K, Sundaram V, Radosevic J, Burnouf T, Seghatchian J, Goubran H

Lähde‎: Transfus Apher Sci 2017;56(3):287-90.

Arkistoitu‎: PubMed 28602484

DOI‎: 10.1016/j.transci.2017.05.014

https://www.ncbi.nlm.nih.gov/pubmed/28602484 (avaa uuden ikkunan)

Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. (avaa uuden ikkunan)

Oh SY, Kim SH, Kwon HC, Lee S, Kim KH, Kwon KA, Lee JH, Lee KY, Kim HJ

Lähde‎: Support Care Cancer 2010;18(10):1341-6.

Arkistoitu‎: PubMed 19841950

DOI‎: 10.1007/s00520-009-0759-3

https://www.ncbi.nlm.nih.gov/pubmed/19841950 (avaa uuden ikkunan)